Article
Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.
International journal of molecular sciences - 7 Dec 2019
Liu Congxing, Witt Lydia, Ianes Chiara, Bischof Joachim, Bammert Marie-Thérèse, Baier Joana, Kirschner Stefan, Henne-Bruns Doris, Xu Pengfei, Kornmann Marko, Peifer Christian, Knippschild Uwe
Abstract excerpt
Protein kinases of the CK1 family can be involved in numerous physiological and pathophysiological processes. Dysregulated expression and/or activity as well as mutation of CK1 isoforms have previously been linked to tumorigenesis. Among all neoplastic diseases, colon and rectal cancer (CRC) represent the fourth leading cause of cancer related deaths. Since mutations in CK1δ previously found in CRC patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
